LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 753

Search options

  1. Article ; Online: Interstitial lung disease in limited cutaneous systemic sclerosis patients: never let your guard down.

    Campochiaro, Corrado / Matucci-Cerinic, Marco

    Rheumatology (Oxford, England)

    2023  Volume 63, Issue 3, Page(s) 589–590

    MeSH term(s) Humans ; Lung Diseases, Interstitial/etiology ; Lung ; Scleroderma, Systemic/complications
    Language English
    Publishing date 2023-09-22
    Publishing country England
    Document type Journal Article
    ZDB-ID 1464822-2
    ISSN 1462-0332 ; 1462-0324
    ISSN (online) 1462-0332
    ISSN 1462-0324
    DOI 10.1093/rheumatology/kead504
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: Editorial: Cardiovascular involvement in autoimmune diseases, volume II.

    Mavrogeni, Sophie I / Fotis, Lambros / Matucci-Cerinic, Marco

    Frontiers in cardiovascular medicine

    2024  Volume 11, Page(s) 1352268

    Language English
    Publishing date 2024-01-31
    Publishing country Switzerland
    Document type Editorial
    ZDB-ID 2781496-8
    ISSN 2297-055X
    ISSN 2297-055X
    DOI 10.3389/fcvm.2024.1352268
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: SAPHO syndrome: Patient stratification and the new horizon of precision medicine.

    Matucci-Cerinic, Caterina / Viglizzo, Gianmaria / Gattorno, Marco

    Seminars in arthritis and rheumatism

    2024  Volume 65, Page(s) 152373

    MeSH term(s) Humans ; Acquired Hyperostosis Syndrome/diagnosis ; Acquired Hyperostosis Syndrome/therapy ; Precision Medicine
    Language English
    Publishing date 2024-01-12
    Publishing country United States
    Document type Letter
    ZDB-ID 120247-9
    ISSN 1532-866X ; 0049-0172
    ISSN (online) 1532-866X
    ISSN 0049-0172
    DOI 10.1016/j.semarthrit.2024.152373
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Book: Skin manifestations in rheumatic disease

    Matucci Cerinic, Marco

    2014  

    Author's details Marco Matucci-Cerinic
    Language English
    Size XVII, 410 S. : Ill., graph. Darst.
    Publisher Springer
    Publishing place New York u.a.
    Publishing country United States
    Document type Book
    HBZ-ID HT017903699
    ISBN 978-1-4614-7848-5 ; 9781461478492 ; 1-4614-7848-0 ; 1461478499
    Database Catalogue ZB MED Medicine, Health

    More links

    Kategorien

  5. Article ; Online: Role of ultrasound in guiding the biopsy site in eosinophilic fasciitis.

    Galluccio, Felice / Cassisa, Angelo / Matucci-Cerinic, Marco

    Rheumatology and immunology research

    2023  Volume 4, Issue 4, Page(s) 219–221

    Language English
    Publishing date 2023-12-19
    Publishing country Germany
    Document type Journal Article
    ISSN 2719-4523
    ISSN (online) 2719-4523
    DOI 10.2478/rir-2023-0032
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Book: Connective tissue diseases

    Matucci-Cerinic, Marco

    (Best practice & research : Clinical rheumatology ; 21,6)

    2007  

    Author's details M. M. Cerinic ..., guest ed
    Series title Best practice & research : Clinical rheumatology ; 21,6
    Best practice & research
    Best practice & research ; Clinical rheumatology
    Collection Best practice & research
    Best practice & research ; Clinical rheumatology
    Language English
    Size S. 970 - 1108 : Ill., graph. Darst.
    Publisher Elsevier
    Publishing place Oxford
    Publishing country Great Britain
    Document type Book
    HBZ-ID HT015548255
    ISBN 978-0-7020-2957-8 ; 0-7020-2957-2
    Database Catalogue ZB MED Medicine, Health

    Kategorien

  7. Book: Heart involvement in autoimmune rheumatic diseases

    Matucci-Cerinic, Marco

    (Rheumatology ; 45, Suppl. 4)

    2006  

    Author's details guest ed.: M. Matucci-Cerinic
    Series title Rheumatology ; 45, Suppl. 4
    Collection
    Language English
    Size iv46 S. : Ill., graph. Darst.
    Publisher Oxford Univ. Press
    Publishing place Oxford
    Publishing country Great Britain
    Document type Book
    HBZ-ID HT014958065
    Database Catalogue ZB MED Medicine, Health

    More links

    Kategorien

  8. Article ; Online: Pre-scleroderma and new opportunities for preventive medicine - Authors' reply.

    Lescoat, Alain / Khanna, Dinesh / Kuwana, Masataka / Allanore, Yannick / Matucci-Cerinic, Marco

    The Lancet. Rheumatology

    2024  Volume 6, Issue 4, Page(s) e201

    Language English
    Publishing date 2024-02-27
    Publishing country England
    Document type Letter
    ISSN 2665-9913
    ISSN (online) 2665-9913
    DOI 10.1016/S2665-9913(24)00058-4
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Response to: 'Correspondence on 'Systemic sclerosis and the COVID-19 pandemic: World Scleroderma Foundation preliminary advice for patient management'' by Snarskaya and Vasileva.

    Bruni, Cosimo / Matucci-Cerinic, Marco

    Annals of the rheumatic diseases

    2021  Volume 82, Issue 2, Page(s) e37

    MeSH term(s) Humans ; COVID-19/epidemiology ; Pandemics ; Scleroderma, Localized/epidemiology ; Scleroderma, Systemic/epidemiology
    Language English
    Publishing date 2021-01-06
    Publishing country England
    Document type Journal Article
    ZDB-ID 7090-7
    ISSN 1468-2060 ; 0003-4967
    ISSN (online) 1468-2060
    ISSN 0003-4967
    DOI 10.1136/annrheumdis-2020-219533
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Immune dysfunction in COVID-19 and judicious use of antirheumatic drugs for the treatment of hyperinflammation

    Tufan, Abdurrahman / Matucci-Cerinic, Marco

    Turkish journal of medical sciences

    2021  Volume 51, Issue SI-1, Page(s) 3391–3404

    Abstract: In the Wuhan province of China, almost two years ago, in December 2019, the novel Coronavirus 2019 has caused a severe involvement of the lower respiratory tract leading to an acute life-threatening respiratory syndrome, coronavirus disease-19 (COVID-19). ...

    Abstract In the Wuhan province of China, almost two years ago, in December 2019, the novel Coronavirus 2019 has caused a severe involvement of the lower respiratory tract leading to an acute life-threatening respiratory syndrome, coronavirus disease-19 (COVID-19). Subsequently, coronavirus 2 (SARS-CoV-2) rapidly spread to the entire world causing a pandemic and affected every single person on earth either directly or indirectly with destroying all facets of social life and economy. Since the announcement of COVID-19 as a global pandemic, we have witnessed tremendous scientific work on all aspects of COVID-19 across the globe, which has never been witnessed before. The most remarkable achievement would be the introduction of vaccines, which provide protection from the severe infection and is the only premise for the control of disease. However, despite the tremendous work, the number of treatments either antiviral or immunomodulatory for infected patients are considerably limited, yet disease is causing substantial morbidity and mortality. COVID-19 follows heterogenous disease course among infected individuals, and dysregulated immune system is primarily responsible for the worse outcomes. Immune deficiency, being on corticosteroids for inflammatory diseases, delayed interferon response and advanced age adversely influence prognosis with impairing viral clearance. On the other hand, exuberant immune response with features of cytokine storm is the leading cause of death, which can be alleviated by use of either general immunosuppression with corticosteroids or selective neutralization of potent pro-inflammatory cytokines such as interleukin (IL)-1 and IL-6. Herein, we summarized the potential effective immunomodulatory treatments emphasizing in which patient population it is the most suitable, which dose should be administered, and which is the most appropriate timepoint to administer the drug during the course of the disease.
    MeSH term(s) Anti-Inflammatory Agents/therapeutic use ; Antirheumatic Agents/therapeutic use ; Antiviral Agents/therapeutic use ; COVID-19/immunology ; Cytokine Release Syndrome ; Cytokines/immunology ; Humans ; Pandemics ; SARS-CoV-2 ; COVID-19 Drug Treatment
    Chemical Substances Anti-Inflammatory Agents ; Antirheumatic Agents ; Antiviral Agents ; Cytokines
    Language English
    Publishing date 2021-12-17
    Publishing country Turkey
    Document type Journal Article ; Review
    ZDB-ID 1183461-4
    ISSN 1303-6165 ; 1300-0144
    ISSN (online) 1303-6165
    ISSN 1300-0144
    DOI 10.3906/sag-2110-179
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top